ZA854168B - 7-(3-aryl-1-piperazinyl)-and 7-(3-cyclohesxyl-1-piperazinyl)-3-quinolonecarboxylic acids - Google Patents

7-(3-aryl-1-piperazinyl)-and 7-(3-cyclohesxyl-1-piperazinyl)-3-quinolonecarboxylic acids

Info

Publication number
ZA854168B
ZA854168B ZA854168A ZA854168A ZA854168B ZA 854168 B ZA854168 B ZA 854168B ZA 854168 A ZA854168 A ZA 854168A ZA 854168 A ZA854168 A ZA 854168A ZA 854168 B ZA854168 B ZA 854168B
Authority
ZA
South Africa
Prior art keywords
carbon atoms
piperazinyl
phenacyl
dimethylamino
acyl
Prior art date
Application number
ZA854168A
Other languages
English (en)
Inventor
Uwe Petersen
Klaus Grohe
Hans-Joachim Zeiler
Karl Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA854168B publication Critical patent/ZA854168B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA854168A 1984-06-04 1985-06-03 7-(3-aryl-1-piperazinyl)-and 7-(3-cyclohesxyl-1-piperazinyl)-3-quinolonecarboxylic acids ZA854168B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843420798 DE3420798A1 (de) 1984-06-04 1984-06-04 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren

Publications (1)

Publication Number Publication Date
ZA854168B true ZA854168B (en) 1986-01-29

Family

ID=6237597

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA854168A ZA854168B (en) 1984-06-04 1985-06-03 7-(3-aryl-1-piperazinyl)-and 7-(3-cyclohesxyl-1-piperazinyl)-3-quinolonecarboxylic acids

Country Status (21)

Country Link
US (1) US4599334A (enExample)
EP (1) EP0169993B1 (enExample)
JP (2) JPS611683A (enExample)
KR (1) KR920000759B1 (enExample)
AT (1) ATE39488T1 (enExample)
AU (1) AU571333B2 (enExample)
CA (1) CA1248954A (enExample)
DD (1) DD240016A5 (enExample)
DE (2) DE3420798A1 (enExample)
DK (1) DK162527C (enExample)
ES (3) ES8607294A1 (enExample)
FI (1) FI82041C (enExample)
GR (1) GR851314B (enExample)
HU (1) HU194866B (enExample)
IE (1) IE57814B1 (enExample)
IL (1) IL75370A (enExample)
NO (1) NO165105C (enExample)
NZ (1) NZ212271A (enExample)
PH (1) PH22492A (enExample)
PT (1) PT80580B (enExample)
ZA (1) ZA854168B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US5468861A (en) * 1984-06-04 1995-11-21 Bayer Aktiengesellschaft 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and alkyl esters thereof
JPS6259263A (ja) * 1985-09-10 1987-03-14 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPH0637489B2 (ja) * 1985-09-21 1994-05-18 杏林製薬株式会社 キノロンカルボン酸誘導体およびその製造方法
DE3683922D1 (de) * 1985-09-24 1992-03-26 Hoffmann La Roche Chinolinderivate.
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
EP0230053A3 (en) * 1986-01-17 1988-03-30 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
HU204512B (en) * 1986-01-20 1992-01-28 Kyorin Seiyaku Kk New process for producing quinoline-carboxylic acid derivatives
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
US4689423A (en) * 1986-04-01 1987-08-25 Warner-Lambert Company Process for the preparation of 2,3,4,5-tetrafluorobenzoyl acetates
HU196987B (en) * 1986-10-15 1989-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing quinoline-carboxylic acid derivatives
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
NZ229605A (en) * 1988-07-15 1990-07-26 Abbott Lab Preparation of 1,4-dihydro-6-fluoro-7-(piperazin-1-yl)-4-oxo-3-quinoline (or naphthyridine) carboxylic acid derivatives
FR2664595B1 (fr) * 1990-07-10 1992-09-18 Bellon Labor Sa Roger Nouveaux derives de benzonaphtyridine-1,8, leur preparation et les compositions qui les contiennent.
FR2653663A1 (en) * 1989-10-30 1991-05-03 Bellon Labor Sa Roger Novel benzo[1,8]naphthyridine derivatives, their preparation and compositions containing them
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
JPH05506033A (ja) 1990-04-18 1993-09-02 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 抗微生物性キノロニルラクタム類
DE10108750A1 (de) * 2001-02-23 2002-09-05 Bayer Ag Verbessertes Verfahren zur Herstellung von Fluorchinoloncarbonsäuren
KR100519158B1 (ko) * 2002-12-21 2005-10-06 주식회사유한양행 퀴놀론 카르복실레이트 유도체의 제조방법
DK2001862T3 (da) * 2006-03-28 2011-08-08 Warner Chilcott Co Llc Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
BRPI0709220A2 (pt) * 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
PE20201257A1 (es) 2018-04-25 2020-11-16 Bayer Animal Health Gmbh Proceso para la hidrolisis de esteres carboxilicos de quinolona

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
DE3142856A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-dichlor-5-fluor-benzoylchlorid
JPS5910580A (ja) * 1982-07-09 1984-01-20 Hokuriku Seiyaku Co Ltd ７−フエニル置換ピペラジノ−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸誘導体
JPS5929685A (ja) * 1982-08-11 1984-02-16 Hokuriku Seiyaku Co Ltd ７−置換フエニルピペラジノ−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸誘導体
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
DE3306772A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Also Published As

Publication number Publication date
EP0169993A3 (en) 1986-03-26
PT80580B (pt) 1987-11-11
FI852205A0 (fi) 1985-05-31
DD240016A5 (de) 1986-10-15
EP0169993B1 (de) 1988-12-28
IL75370A0 (en) 1985-09-29
NO852063L (no) 1985-12-05
ES8800195A1 (es) 1987-11-01
NZ212271A (en) 1988-10-28
ES8607294A1 (es) 1986-06-01
ES552573A0 (es) 1987-11-01
KR860000280A (ko) 1986-01-27
AU571333B2 (en) 1988-04-14
JPS611683A (ja) 1986-01-07
IE851364L (en) 1985-12-04
ES543839A0 (es) 1986-06-01
ES552574A0 (es) 1987-11-01
DK249685A (da) 1985-12-05
PT80580A (en) 1985-07-01
DE3420798A1 (de) 1985-12-05
FI82041C (fi) 1991-01-10
EP0169993A2 (de) 1986-02-05
JPH06279411A (ja) 1994-10-04
FI82041B (fi) 1990-09-28
NO165105C (no) 1990-12-27
GR851314B (enExample) 1985-11-25
CA1248954A (en) 1989-01-17
KR920000759B1 (ko) 1992-01-21
DK162527B (da) 1991-11-11
DE3567021D1 (en) 1989-02-02
ATE39488T1 (de) 1989-01-15
ES8800196A1 (es) 1987-11-01
IL75370A (en) 1989-03-31
HU194866B (en) 1988-03-28
PH22492A (en) 1988-09-12
DK249685D0 (da) 1985-06-03
DK162527C (da) 1992-03-30
HUT39175A (en) 1986-08-28
IE57814B1 (en) 1993-04-21
AU4320685A (en) 1985-12-12
FI852205L (fi) 1985-12-05
NO165105B (no) 1990-09-17
CA1259315C (enExample) 1989-09-12
US4599334A (en) 1986-07-08

Similar Documents

Publication Publication Date Title
ZA854168B (en) 7-(3-aryl-1-piperazinyl)-and 7-(3-cyclohesxyl-1-piperazinyl)-3-quinolonecarboxylic acids
LU88361I2 (fr) Excenel
JPS5334794A (en) Cephalosporin derivatives and their preparation
JPS5353691A (en) 3,7-di-substituted-3-cephem-4 carboxylic acid derivatives, their salts andtheir preparation
PT81792A (en) Process for preparing basic compositions of quinolone carboxylic acids
AR241593A1 (es) Procedimiento para preparar derivados de acido quinolin-3-carboxilico.
DE3673133D1 (de) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel.
KR860002489A (ko) 4,5-디히드로-4-옥소-2-[(2-트랜스-페닐시클로프로필)아미노]-2-푸란카복실산 및 이의 유도체의 제조방법
ATE45738T1 (de) 1-cyclopropyl-1,4-dihydro-4-oxo-7-(4-(2-oxo-1,3 dioxol-4-yl-methyl)-1-piperazinyl>-3chinolincarbons|uren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel.
ES543837A0 (es) Acidos 1-ciclopropil-6-fluor-1,4-dihidro-4-oxo-7-(3-oxo-1- piperazinil)-3-quinolin-carboxilicos
ZA855156B (en) Novel ether-oxides derived from cyclopropylphenols
KR830004320A (ko) 퀴나졸린 유도체의 제조방법
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
IE33537L (en) Cephem-carboxylic acid esters
GB2282810A (en) Process for the preparation of clavulanic acid
JPS5283779A (en) 7-alpha,alpha-disubstituted acetamide-3-alkanoyloxymethyl-3-cephem-4-carboxyli c acid or its carboxyderivative and its salt
SE8107683L (sv) Xantinderivat
FI922482L (fi) Foerfarande foer framstaellning av kinolinfoerening.